CADM1 and central nervous system cancer: High expression of HOXA11-AS and AB073614 is able to strengthen the proliferation and might serve as an unfavorable prognosis predictor for glioma [16,17], whereas lncRNA TSLC1 antisense RNA (TSLC1-AS1) has been characterized as a glioma suppressor and could serve as a biomarker and novel therapeutic target for glioma patients [18].